MedTrace Logo

Scheduled Autologous PRP Guided Injection in the Maxillary Bony Defects

NCT07108933 · Status: COMPLETED · Phase: PHASE2 · Type: INTERVENTIONAL · Enrollment: 16

Last updated 2025-08-07

No results posted yet for this study

Summary

Scheduled autologous platelet-rich plasma guided injection is done in critical-sized maxillary bony defects after surgical excision of non- malignant lesions.

Conditions

  • Bony Defect

Interventions

BIOLOGICAL

Autologous platelet-rich plasma

Guided injection of PRP in bony cavities of maxilla after surgical excision of non-malignant tumors.

Sponsors & Collaborators

  • Horus University

    lead OTHER

Principal Investigators

  • Eman Abdel Salam, Prof · Head of department of Oral Surgery

Study Design

Allocation
NA
Purpose
TREATMENT
Masking
NONE
Model
SINGLE_GROUP

Eligibility

Min Age
18 Years
Max Age
45 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2023-08-15
Primary Completion
2024-10-15
Completion
2025-04-15

Countries

  • Egypt

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT07108933 on ClinicalTrials.gov